RecallRadar

FDA Drug recall D-0231-2022

Tadalafil Tablets, USP 20 mg, 30 count bottle, Rx Only, Manufactured for: Northstar Rx LLC Memphis, TN 38141, Manufactured by: Sun Pharmace…

On 2021-11-17 the FDA classified a Class II recall of Tadalafil Tablets, USP 20 mg, 30 count bottle, Rx Only, Manufactured for: Northstar Rx LLC Memphis, TN 38141, Manufactured by: Sun Pharmace… by Sun Pharmaceutical Industries, citing incorrect Product Formulation: An incorrect grade of Crospovidone was used to manufacture the product.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0231-2022
ClassificationClass II
Statusterminated
Initiated2021-10-25
Published2021-11-17
Last updated2026-09-13 11:52 UTC
CompanySun Pharmaceutical Industries
DistributionUS

Product

Tadalafil Tablets, USP 20 mg, 30 count bottle, Rx Only, Manufactured for: Northstar Rx LLC Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Industries Limited, India, NDC # 16714-077-01

Reason

Incorrect Product Formulation: An incorrect grade of Crospovidone was used to manufacture the product.

Identifiers

ndc16714-074-01
ndc16714-074-02
ndc16714-075-01
ndc16714-076-01
ndc16714-077-01
code_infoLot # DNC0814A, DNC0815A, Exp. Date 04/2023

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0231-2022%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.